Tren de Aragua, a criminal Venezuelan transnational organization known for committing major international crimes such as human trafficking, drug-trafficking, arms trafficking, and money laundering, continues to terrorize communities across our nation. Following calls...
News
Latest News
Rubio Introduces Bill Demanding Cuban Regime Extradite American Fugitives and Terrorists
Since dictator Fidel Castro took power in Cuba, the regime has offered a safe haven to criminal fugitives seeking to escape justice. Currently, there are at least 90 fugitives receiving safe harbor in Cuba. From convicted felon Joanne Chesimard, to William “Guillermo”...
Next Week: Rubio Staff Hosts Mobile Office Hours
In-person Mobile Office Hours Tuesday, September 24, 2024 Collier County 11:00am – 1:00pm EDT Immokalee Library 417 N 1st St. Immokalee, FL 34142 Click Here Jefferson County 3:00pm – 4:30pm EDT Monticello – Jefferson County Chamber of Commerce 420 W. Washington St....
Rubio: Biden-Harris State Department Mishandled Suspension of U.S. Envoy to Iran
Following the suspension of Rob Malley, the U.S. Special Envoy for Iran, for being a potential counterintelligence threat, Republican Senators demanded an investigation into the Biden-Harris Administration’s actions. The Office of the Inspector General (OIG) concluded...
ICYMI: Rubio Warns of China Shock 2.0
China’s trade manipulations will devastate us—it’s time to fight back U.S. Senator Marco Rubio (R-FL) September 19, 2024 New York Post Industries reel, companies crumble, and factories close their doors for good…. This could be a description of the original “China...
Rubio Introduces Bill to Prevent Communist China From Evading U.S. Tariffs
Under the Trump Administration, Chinese-manufactured imports were subject to large tariffs. China countered with a multi-pronged strategy to evade U.S. tariffs and trade restrictions. Recently, Chinese manufacturers have exploited a loophole in U.S. trade law by...
Rubio Secures Provision to Address DOD Supply Chain Dependence on Foreign Pharmaceuticals in Defense Bill
Washington, D.C. — U.S. Senator Marco Rubio (R-FL) secured a pharmaceutical supply chain report (Sec. 713) in the National Defense Authorization Act (NDAA) for Fiscal Year 2021 (H.R. 6395) conference report that requires the Secretary of Defense to conduct an industrial capacity vulnerability study of the Department of Defense’s (DoD) dependence on foreign-made pharmaceuticals. The provision was maintained in the final conference report after having passed the Senate unanimously. The Senate’s action sends the final conference report to the President.
This language mirrors Rubio’s bipartisan and bicameral Strengthening America’s Supply Chain and National Security Act (S. 3538), which seeks to combat America’s supply chain risk and dependence on China for pharmaceuticals. This bill would also require drugmakers to provide the Food and Drug Administration (FDA) with information to determine the volume of APIs used in pharmaceuticals — a provision that was enacted earlier this year in the CARES Act.
Rubio’s provision builds upon the bipartisan legislation he introduced earlier this year that would for the first time provide data and study the effects of America’s overreliance on foreign countries and foreign direct investment in our domestic pharmaceutical supply chain.
“Nearly two years ago, I warned that our nation has critical vulnerabilities and supply chain risks in pharmaceuticals and other key sectors of our economy as a result of decades of lost industrial capacity to China,” Rubio said. “That vulnerability includes the DoD’s dependence on China for pharmaceuticals, and I was proud to secure this critical provision in the FY21 NDAA conference report to ensure that the DoD has the necessary information to assess and ultimately reduce our overreliance on China for pharmaceuticals and medical countermeasures. The coronavirus pandemic has made it painfully clear that we must take decisive action to rebuild our nation’s medical manufacturing sector.”
In August, Rubio introduced the Medical Manufacturing, Economic Development, and Sustainability (MMEDS) Act of 2020 (S.4467), bipartisan legislation which encourages companies currently producing medical and pharmaceutical equipment abroad to relocate to the U.S. The bill would also enact a tax credit of federal income tax liability for wages and eligible pharmaceutical manufacturing facilities in economically distressed zones, including Puerto Rico.
In March, Rubio and Warren introduced bipartisan legislation to combat America’s supply chain risk and dependence on China for pharmaceuticals that builds off the plan he released. More than a year ago, Rubio issued a report detailing critical vulnerabilities in America’s medical supply chain, warning, “the U.S. runs the risk of losing important components of its medical supply chain to China’s government-backed industry.” Last year, Rubio warned in Modern Healthcare that when it comes to the threat China poses to the U.S. healthcare industry, we cannot afford to be complacent.
The United States relies heavily on foreign nations for its supply of drugs and pharmaceutical products. Today, experts estimate up to 80% of the active pharmaceutical ingredients (APIs), the requisite component of drugs, are imported from abroad. This overreliance leaves our supply chain of critical drugs used by millions of Americans vulnerable to disruption — whether by accident or by design.